T-cell epitopes in variable segments of Chlamydia trachomatis major outer membrane protein elicit serovar-specific immune responses in infected humans

被引:40
作者
Ortiz, L
Angevine, M
Kim, SK
Watkins, D
DeMars, R
机构
[1] Univ Wisconsin, Genet Lab, Madison, WI 53706 USA
[2] Univ Wisconsin, Sch Med, Dept Med, Madison, WI 53706 USA
[3] Univ Wisconsin, Sch Med, Dept Med Microbiol & Immunol, Madison, WI 53706 USA
[4] Univ Wisconsin, Sch Med, Dept Pathol, Madison, WI 53706 USA
关键词
D O I
10.1128/IAI.68.3.1719-1723.2000
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
We previously identified 18 stimulatory Chlamydia trachomatis major outer membrane protein (MOMP) peptides containing at least 23 epitopes presented with various HLA class II allotypes, Only one peptide contained an epitope localized in a variable segment (VS2), Continued studies reported here identified a total of five VS peptides containing T-cell epitopes that are distributed among MOMPs VS1, VS2, and VS4, Only MOMP-primed T-cell cultures from subjects infected with serovar E responded to the serovar E VS peptides, while the response of such cultures to constant-segment peptides was independent of the infecting serovar, Furthermore, MOMP-primed T cells proliferated in response only to the VS peptides encoded in serovar E but not to the corresponding peptides derived from serovar F, I, or J, confirming that these responses were serovar specific.
引用
收藏
页码:1719 / 1723
页数:5
相关论文
共 21 条
[1]  
ALANI MD, 1977, BRIT J VENER DIS, V53, P88
[2]   Identification of T cells that respond to serovar-specific regions of the Chlamydia trachomatis major outer membrane protein in persons with serovar E infection [J].
Arno, JN ;
Xie, CP ;
Jones, RB ;
Van der Pol, B .
JOURNAL OF INFECTIOUS DISEASES, 1998, 178 (06) :1713-1718
[3]  
BATTEIGER BE, 1998, CHLAMYDIAL INFECT, P462
[4]   ROLE OF DISULFIDE BONDING IN OUTER-MEMBRANE STRUCTURE AND PERMEABILITY IN CHLAMYDIA-TRACHOMATIS [J].
BAVOIL, P ;
OHLIN, A ;
SCHACHTER, J .
INFECTION AND IMMUNITY, 1984, 44 (02) :479-485
[5]   WORKSHOP ON IN-VITRO NEUTRALIZATION OF CHLAMYDIA-TRACHOMATIS - SUMMARY OF PROCEEDINGS [J].
BYRNE, GI ;
STEPHENS, RS ;
ADA, G ;
CALDWELL, HD ;
SU, H ;
MORRISON, RP ;
VANDERPOL, B ;
BAVOIL, P ;
BOBO, L ;
EVERSON, S ;
HO, Y ;
HSIA, RC ;
KENNEDY, K ;
KUO, CC ;
MONTGOMERY, PC ;
PETERSON, E ;
SWANSON, A ;
WHITAKER, C ;
WHITTUMHUDSON, J ;
YANG, CL ;
ZHANG, YX ;
ZHONG, GM .
JOURNAL OF INFECTIOUS DISEASES, 1993, 168 (02) :415-420
[6]   PRESENTATION OF SOLUBLE-ANTIGEN TO HUMAN-T CELLS BY PRODUCTS OF MULTIPLE HLA-LINKED LOCI - ANALYSIS OF ANTIGEN PRESENTATION BY A PANEL OF CLONED, AUTOLOGOUS, HLA-MUTANT EPSTEIN-BARR VIRUS-TRANSFORMED LYMPHOBLASTOID CELL-LINES [J].
CHEN, BP ;
DEMARS, R ;
SONDEL, PM .
HUMAN IMMUNOLOGY, 1987, 18 (01) :75-91
[7]   Molecular and mutation trends analyses of omp1 alleles for serovar E of Chlamydia trachomatis - Implications for the immunopathogenesis of disease [J].
Dean, D ;
Millman, K .
JOURNAL OF CLINICAL INVESTIGATION, 1997, 99 (03) :475-483
[8]   Virus-specific cytotoxic T-lymphocyte responses select for amino-acid variation in simian immunodeficiency virus Env and Nef [J].
Evans, DT ;
O'Connor, DH ;
Jing, PC ;
Dzuris, JL ;
Sidney, J ;
da Silva, J ;
Allen, TM ;
Horton, H ;
Venham, JE ;
Rudersdorf, RA ;
Vogel, T ;
Pauza, CD ;
Bontrop, RE ;
DeMars, R ;
Sette, A ;
Hughes, AL ;
Watkins, DI .
NATURE MEDICINE, 1999, 5 (11) :1270-1276
[9]   POTENTIAL FOR VACCINE AGAINST INFECTION OF GENITAL-TRACT WITH CHLAMYDIA-TRACHOMATIS [J].
GRAYSTON, JT ;
WANG, SP .
SEXUALLY TRANSMITTED DISEASES, 1978, 5 (02) :73-77
[10]   The changing paradigm of sexually transmitted disease control in the era of managed health care [J].
Gunn, RA ;
Rolfs, RT ;
Greenspan, JR ;
Seidman, RL ;
Wasserheit, JN .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1998, 279 (09) :680-684